Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX W DEXTROSE 1 5 LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER versus DELFLEX W DEXTROSE 2 5 LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DELFLEX W DEXTROSE 1 5 LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER versus DELFLEX W DEXTROSE 2 5 LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER.
DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER vs DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Peritoneal dialysis solution; dextrose provides osmotic gradient for ultrafiltration; electrolytes correct imbalances; low magnesium and calcium adjust levels in renal failure.
Peritoneal dialysis solution; dextrose provides osmotic gradient for ultrafiltration and solute removal; low magnesium and low calcium concentrations maintain electrolyte balance.
Intraperitoneal administration: 2 liters per exchange, 4 exchanges per day, or 8-10 liters over 10-12 hours for overnight cycler, with dextrose concentration selected based on ultrafiltration needs.
Intraperitoneal: 2.5% dextrose solution with low magnesium (0.25 mEq/L) and low calcium (2.5 mEq/L); typical exchange volume 2-2.5 L per exchange, 4-5 exchanges per day for continuous ambulatory peritoneal dialysis.
None Documented
None Documented
Not applicable as a terminal half-life for the solution itself; glucose absorption half-life from peritoneal cavity is approximately 2-4 hours, reflecting peritoneal clearance. There is no systemic accumulation of the solution's components beyond expected glucose metabolism.
Dextrose: 1.5–2 hours (intracellular metabolism); Magnesium: 27–40 hours; Calcium: 2.5–3 hours (exchangeable pool); Low concentrations do not alter endogenous kinetics.
Primarily eliminated via peritoneal drainage during continuous ambulatory peritoneal dialysis (CAPD). Approximately 60-80% of glucose is absorbed across the peritoneum and metabolized systemically; non-metabolized glucose and other solutes are removed in dialysate effluent. Renal excretion is negligible (<5%) in patients with end-stage renal disease on CAPD.
Renal: 100% (unchanged dextrose and electrolytes; magnesium and calcium are partially reabsorbed, but net excretion is via urine). Biliary/fecal: negligible.
Category C
Category C
Peritoneal dialysis solution
Peritoneal dialysis solution